Prelude Therapeutics
Why Robinhood?
Robinhood gives you the tools you need to put your money in motion. You can buy or sell PRLD and other ETFs, options, and stocks.About PRLD
Prelude Therapeutics, Inc. is a clinical-stage oncology company, which engages in the development of novel precision cancer medicines. It also focuses on the design and development of small molecule agents for cancer medicines.
PRLD Key Statistics
Stock Snapshot
As of today, Prelude Therapeutics(PRLD) shares are valued at $2.93. The company's market cap stands at 162.49M, with a P/E ratio of -1.78.
On 2026-02-27, Prelude Therapeutics(PRLD) stock opened at $3.23, reached a high of —, and a low of —.
Prelude Therapeutics(PRLD) shares are trading with a volume of 0, against a daily average of 429.53K.
During the past year, Prelude Therapeutics(PRLD) stock moved between $0.61 at its lowest and $4.22 at its peak.
During the past year, Prelude Therapeutics(PRLD) stock moved between $0.61 at its lowest and $4.22 at its peak.
People also own
Similar Marketcap
This list is generated by looking at the six larger and six smaller companies by market cap in relation to this company.
Popular Stocks
This list is generated by looking at the top 100 stocks and ETFs most commonly held by Robinhood customers and showing a random subset
Newly Listed
This list is generated by showing companies that recently went public.